Like YouScript, Inc.

announced 3/11/2020 via Company Press Release

InVitae, will acquire YouScript, Inc.

synopsis: Invitae Corportation, a leading medical genetics company, will acquire YouScript, a clinical decision support and analytics platform that enables more proactive medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service. "
target: YouScript, Inc.
YouScript a clinical decision support and analytics platform that enables faster, more proactive personalized medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/11/2021 via Company Press Release

Servelec Limited, acquired Elemental Software

synopsis: Servelec, the leading supplier of digital care software in the UK, has acquired Elemental Software, a social prescribing software company in the UK. Elemental’s digital social prescribing platform makes it easier to make, manage, track and measure social prescribing referrals and the impact they have on a communities health and wellbeing.
buyer parent: Montagu Private Equity
buyer: Servelec Limited (LSE:SERV:$91.22)
Servelec is the leading supplier of digital care software across health, social care, education and youth services in the UK. Servelec offers software solutions for Electronic Patient Records, social care case management, patient flow & bed management, education management, and more. "
target: Elemental Software
Elemental Software an award-winning social prescribing software company in the UK. Elemental’s digital social prescribing platform makes it easier to make, manage, track and measure social prescribing referrals and the impact they have on a communities health and wellbeing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2020 via BNC Analysis

GoodRx, Inc., acquired Scriptcycle LLC

synopsis: GoodRx, a website and a mobile app that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the US, has acquired Scriptcycle, a healthcare technology company that provides prescription processing and adjudication services to patients, pharmacies, and employers.
buyer parent: Francisco Partners Management LLC
buyer: GoodRx, Inc.
GoodRx helps Americans save on their prescriptions. It offers a website and a mobile app that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the US. "
target: Scriptcycle LLC
Scriptcycle is a healthcare technology company that provides prescription processing and adjudication services to patients, pharmacies, and employers. They offer Prescription Processing & Adjudication, Preferred Prescription Savings Programs, and Transparent Prescription Benefit Management.
price ($mm)
$57
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/21/2020 via PR Newswire

HealthVerity, acquired Curisium

synopsis: HealthVerity, the leader in privacy-protected data exchange, announced that it has acquired Curisium, an innovator in cloud-based drug rebate processing and contract performance management.
buyer: HealthVerity
HealthVerity has emerged as a leader and key partner to nearly 75% of top pharmaceutical manufacturers and payers, having fundamentally changed the way that key healthcare organizations secure, exchange and synthesize HIPAA-protected information at scale. "
target: Curisium
Curisium is an innovator in cloud-based drug rebate processing and contract performance management. Curisium's cutting-edge platform enables payers, pharmaceutical manufacturers and providers to enter into innovative contracting arrangements in a secure, efficient, scalable, data-driven way.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2020 via Company Press Release

Main Capital Partners BV, acquired Alfa Kommun & Landsting AB and Safe Care Svenska AB

synopsis: Main Capital has acquired a majority stake in eHealth software group Alfa Kommun & Landsting AB and Safe Care Svenska AB, together referred to as Alfa. Alfa’s broad offering includes both complete information systems and niche products, such as solutions for journaling, electronic prescription, medication management and care planning.
buyer: Main Capital Partners BV
Netherlands-based Main Capital is a strategic investor with an exclusive focus on the software sector in the Benelux, Germany, Austria, Switzerland, and Nordics regions. Within this sector, Main Capital is the most specialized company in management buyouts and later-stage growth capital. "
target: Alfa Kommun & Landsting AB and Safe Care Svenska AB
Alfa Group is a Swedish eHealth software group consisting of Alfa Kommun & Landsting AB and Safe Care Svenska AB. Alfa’s broad offering includes both complete information systems and niche products, such as solutions for journaling, electronic prescription, medication management and care planning.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/9/2019 via Company Press Release

Express Scripts Inc., acquired Verity Solutions

synopsis: Verity Solutions, an award-winning leader in software and services developed for administration of the federal 340B drug pricing program, has been acquired by Express Scripts, a Cigna company. Verity Solutions simplifies the complex process of maintaining 340B PROGRAM compliance resulting in critical 340B cost savings for their customers.
buyer parent: CIGNA Corporation
buyer: Express Scripts Inc. (ESRX:$100,275.80)
Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. "
target: Verity Solutions
Verity Solutions is an award-winning leader in software and services developed for administration of the federal 340B drug pricing program. Verity Solutions simplifies the complex process of maintaining 340B PROGRAM compliance resulting in critical 340B cost savings for their customers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2019 via BNC Analysis

Allscripts, acquired ZappRx

synopsis: Medical software company Allscripts has bought ZappRx, a start-up that aimed to modernize how people access prescription medicines. ZappRx was founded in 2012 in Boston, Mass. ZappRx specializes in helping people access the class of so-called specialty medicines, which includes expensive and high-complex or high-cost interventions.
buyer: Allscripts (MDRX:$1,718.10)
Allscripts is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Their solutions connect people, places and data across an Open, Connected Community of Health. Connectivity empowers caregivers to deliver care for healthier populations. "
target: ZappRx
ZappRx is a digital health company offering a prescription and prior authorization (“PA”) platform; their goal is to streamline and increase efficiencies in the way specialty medications reach patients. ZappRX provides a secure, collaborative online platform to improve patients’ access to treatment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2019 via BNC Analysis

Netmeds Marketplace Limited, acquired KiViHealth

synopsis: Online pharmacy NetMeds Marketplace Pvt. Ltd has acquired health-tech startup KiViHealth. KiViHealth is a clinic management platform that allows doctors to generate digital prescriptions. It also offers electronic historical health records storage. The KiViHealth app also provides an appointment booking module and a patient engagement tool.
buyer: Netmeds Marketplace Limited
NetMeds lets users order their medicines via its portal and mobile app by uploading their prescriptions. A team of qualified pharmacists verifies the prescription for validity and prescribes the appropriate dosage accordingly. NetMeds is based in Chennai, India. "
target: KiViHealth
KiViHealth is a clinic management platform that allows doctors to generate digital prescriptions. It also offers electronic historical health records storage. The KiViHealth app also provides an appointment booking module and a patient engagement tool, along with billing invoicing solutions.
price ($mm)
$10
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/8/2020 via BNC Analysis

IngenioRx, acquired Zipdrug, Inc.

synopsis: Anthem’s pharmacy benefit manager, IngenioRx, has acquired Zipdrug, a healthcare company that facilitates in-home drug delivery and helps health plans track medication adherence. The acquisition gives IngenioRx access to Zipdrug’s services and the ability to sell them to health plans as part of its offering or as a standalone pharmacy service.
buyer parent: Anthem, Inc.
buyer: IngenioRx
IngenioRx provides pharmacy benefit management services to payers, including affiliates of Anthem, Inc. The company offers a whole health approach that helps drive better outcomes and lowers member, employer, and plan costs. "
target: Zipdrug, Inc.
ZipDrug is a data-driven healthcare company bringing better outcomes to patients and payers and increased revenue and reputation to partner pharmacies. ZipDrug simplifies the pharmacy experience by connecting patients to pharmacies and delivering lower cost prescriptions directly to their door.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/10/2020 via GlobeNewswire

Health Catalyst, will acquire healthfinch

synopsis: Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, is to acquire healthfinch, Inc., a Madison, Wisconsin-based company that provides a workflow integration engine delivering insights and analytics into EMR workflows to automate physicians’ ability to close patient care gaps in real-time.
buyer: Health Catalyst (HCAT:$199.57)
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. The company's customers leverage the cloud-based analytics software data platform to make data-informed decisions and realize measurable clinical, financial, and operational improvements."
target: healthfinch
healthfinch has developed the healthcare industry's most trusted, most used clinical workflow optimization solution, Charlie. Charlie streamlines key workflows such as prescription renewal processing, visit planning, and care gap closure.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/14/2020 via PR Web

Amsys Group, acquired HealthConnexx LLC

synopsis: AMSYS Group, an international group of companies, has acquired HealthConnexx, a healthcare technology company. HealthConnexx, through its RxConnexx platform, connects providers, patients, payers, pharmacies, and pharmaceutical companies to prescription medication information to enable better clinical outcomes through real-time data.
buyer: Amsys Group
AMSYS Group is a 17-year old firm with experience in multiple verticals. IT is their flagship vertical. The group offers a variety of managed IT services and IT staffing solutions. Their other verticals include emerging tech, telecom engineering, oil and gas services, compliance, and healthcare. "
target: HealthConnexx LLC
HealthConnexx is an innovator for healthcare data liquidity and accessibility. The HealthConnexx RxConnexx platform is the first real-time patient data exchange platform for medication and benefits data, bringing immediate clarity and actionable information for everyone in the healthcare continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2012 via BusinessWire

Pharmaceutical Strategies Group, LLC, acquired Artemetrx

synopsis: Pharmaceutical Strategies Group, LLC, America’s largest independent pharmacy benefits consulting firm, has closed on its acquisition of Artemetrx Health Resources. Artemetrx offers data analytic tools and clinical programs that integrate pharmacy, medical, and other healthcare information.
buyer: Pharmaceutical Strategies Group, LLC
Pharmaceutical Strategies Group, LLC assists plan sponsors and other payors, Taft-Hartley Unions, large employers, and health systems in designing, implementing, and managing programs that maximize the value and impact of pharmaceuticals in their population. "
target: Artemetrx
At the core of the Artemetrx service offering is a robust proprietary data aggregation engine that combines behavioral, medical, dental, vision, lab, and prescription drug data to provide a comprehensive view of health-related utilization and expenditures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/12/2021 via GlobeNewswire

CloudMD Software & Services Inc., acquired Rx Infinity Inc.

synopsis: CloudMD Software & Services Inc. has acquired Rx Infinity Inc., Rxi Pharmacy Inc., and Rxi Health Solutions Inc., (collectively “Rxi”). Rxi’s pharmaceutical logistic services include drug distribution, patient navigation assistance, a preferred pharmacy network of over 500 pharmacies and real time universal disease management software.
buyer: CloudMD Software & Services Inc. (CNSX:PHGI:$9.28)
CloudMD is digitizing the delivery of healthcare by providing a patient centric approach, with an emphasis on continuity of care. The Company offers SAAS based health technology solutions to healthcare providers across North America. "
target: Rx Infinity Inc.
Rxi’s pharmaceutical logistic services include drug distribution, patient navigation assistance, a preferred pharmacy network of over 500 pharmacies and real time universal disease management software. They are based in Canada.
price ($mm)
$5.11
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via GlobeNewswire

Inovalon, Inc., acquired Creehan & Company

synopsis: Inovalon has completed its acquistion of Creehan Holding Co., Inc., the parent company of Creehan & Company, an independent provider of specialty pharmacy and specialty medications management software-as-a-service platforms. Creehan & Company’s software platform is utilized by approximately 30% of the specialty pharmacy market.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Creehan & Company
Creehan & Company is the healthcare technology industry’s leading third-party provider of SaaS and on-premise enterprise-wide software application platforms and implementation services for standalone specialty pharmacies and other industry players.
price ($mm)
$105
rev ($mm)
$27
EBITDA ($mm)
EV / rev
4.8x
EV / EBITDA
closed 2/19/2020 via Company Press Release

Inmar Inc., acquired RXTransparent

synopsis: Inmar has announced that it has acquired Forerunner Holdings Inc., the developers of RXTransparent, an SAAS platform allowing healthcare providers to put their finger on the pulse of drug supply chain through product inventory transparency, regulatory compliance and supply chain analytics.
buyer parent: OMERS Private Equity
buyer: Inmar Inc.
Inmar’s holistic portfolio of media products enables advertisers to access a variety of intelligent tools, including its influencer media platform, conversational commerce (chat-based media), audience extension and on-site digital media for retail. "
target: RXTransparent
Forerunner Holdings Inc. are the developers of RXTransparent, an SAAS platform allowing healthcare providers to put their finger on the pulse of drug supply chain through product inventory transparency, regulatory compliance and supply chain analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2019 via GlobeNewswire

Tabula Rasa Healthcare, acquired DoseMe

synopsis: Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the field of medication safety, has acquired DoseMe. DoseMe is the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications. DoseMe is based in the US and Australia.
buyer: Tabula Rasa Healthcare (TRHC:$204.27)
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize patient outcomes, lower healthcare costs and improve organizational performance. "
target: DoseMe
DoseMe is the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2016 via BusinessWire

Rx30 Pharmacy System, acquired vMEDEX, Inc.

synopsis: Transaction Data Systems, Inc., doing business as Rx30, announced that Rx30 has completed its acquisition of vMEDEX. vMEDEX has been a valued integration partner over the past 3 years, demonstrating an innovative approach to providing advanced clinical services functionality.
buyer: Rx30 Pharmacy System
Rx30 is a total Pharmacy Management Software application that truly acts as the hub for all pharmacy management activities, including prescription dispensing, fully automated refills and reminders, workflow management, adherence management, document management, smart phone/web refills and more. "
target: vMEDEX, Inc.
vMEDEX is a healthcare Software as a Service company. Healthcare practitioners are able to care for more patients with greater quality and consistency using vMEDEX powered solutions. vMEDEX deliver expert healthcare assistance when and where it is needed most to protect those most vulnerable.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/29/2021 via GlobeNewswire

Pharmagest Interactive S.A., acquired Prokov Editions

synopsis: Pharmagest Group, a leading pharmacy IT organization in Europe, has acquired Prokov Editions, a leading provider of medical software for Mac computers and iOS devices in France. Prokov Editions offers a practice management system that provides solutions for medical records, appointments, prescriptions, invoicing, reporting, and more.
buyer parent: Asca Informatique
buyer: Pharmagest Interactive S.A. (ENXTPA:PHA:$199.39)
Pharmacist Group is a leading pharmacy information technology organization in Europe. The Group improves healthcare through IT innovation and the development of services and technologies for healthcare professionals, as well as technologies for improving the efficacy of healthcare systems. "
target: Prokov Editions
Prokov Editions is a leading provider of medical software for Mac computers and iOS devices in France. Prokov Editions' flagship software, MédiStory, is a practice management system that provides solutions for medical records, appointments, prescriptions, invoicing, reporting, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2017 via BusinessWire

SUNRx, Inc., acquired eAudit Solutions

synopsis: SUNRx, a compliance-focused 340B contract pharmacy administrator, announced that it acquired eAudit Solutions, which provides 340B software and services to hospitals, to offer covered entities an end-to-end solution by adding split-billing capabilities to 340B contract pharmacy management.
buyer parent: MedImpact Healthcare Systems, Inc.
buyer: SUNRx, Inc.
Based in Bensalem, PA, SUNRx is the industry innovator in managing 340B programs that expand access to affordable medications, provide financial benefits to the hospital and its uninsured, and that meet the highest levels of regulatory compliance. "
target: eAudit Solutions
eAudit Solutions provides 340B software and services to hospitals to offer covered entities an end-to-end solution by adding split-billing capabilities to 340B contract pharmacy management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/12/2017 via Company Press Release

Marc Lemchen and Todd Blankenbecler, acquired EasyRx LLC

synopsis: Board members Dr. Marc Lemchen and Todd Blankenbecler have acquired a majority interest in EasyRx, a revolutionary "Universal"​ system that allows orthodontists and dentists to design, create, manage, and submit their patient’s appliance prescriptions online to ANY orthodontic laboratory in the world or in-house lab.
buyer: Marc Lemchen and Todd Blankenbecler
Marc Lemchen and Todd Blankenbecler are both Board Members of the company EasyRx. Together they acquired the company and will join as management. "
target: EasyRx LLC
EasyRx is a revolutionary "Universal"​ system that allows orthodontists and dentists to design, create, manage, and submit their patient’s appliance prescriptions online to ANY orthodontic laboratory in the world or in-house lab.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/11/2020 via Company Press Release

InVitae, will acquire YouScript, Inc.

synopsis: Invitae Corportation, a leading medical genetics company, will acquire YouScript, a clinical decision support and analytics platform that enables more proactive medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service. "
target: YouScript, Inc.
YouScript a clinical decision support and analytics platform that enables faster, more proactive personalized medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/8/2021 via PR Newswire

InVitae, will acquire Ciitizen

synopsis: Invitae will acquire Ciitizen, a patient-centric consumer health tech company. The acquisition will enhance Invitae's platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information, which together comprise a powerful dataset with the potential to drive research and improve healthcare decision making.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company that brings comprehensive genetic information into mainstream medicine to improve healthcare. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Ciitizen
Ciitizen is a leading consumer health technology company whose mission is to help patients get full control of their medical records to access and find better treatment options including participation in research and finding clinical trials.
price ($mm)
$325
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/11/2020 via Company Press Release

InVitae, will acquire YouScript, Inc.

synopsis: Invitae Corportation, a leading medical genetics company, will acquire YouScript, a clinical decision support and analytics platform that enables more proactive medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service. "
target: YouScript, Inc.
YouScript a clinical decision support and analytics platform that enables faster, more proactive personalized medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/11/2020 via PR Newswire

InVitae, acquired Diploid

synopsis: Invitae Corporation, a leading medical genetics company, has acquired Diploid, a privately held Belgian company that developed Moon, artificial intelligence (A.I.) software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company that brings comprehensive genetic information into mainstream medicine to improve healthcare. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Diploid
Belgium-based Diploid provides clinical labs, hospitals, and nation-wide sequencing programs with the tools to diagnose every rare disease patient. Its Moon platform uses AI software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
price ($mm)
$95
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/20/2019 via Company Press Release

InVitae, will acquire Clear Genetics

synopsis: Invitae Corporation, one of the fastest growing genetic information companies in the U.S., will acquire Clear Genetics, a leading developer of software for providing genetic services at scale whose HIPAA-compliant platform offers an automated and comprehensive solution to deliver genetic services at scale.
buyer: InVitae (NVTA:$389.09)
Invitae is one of the fastest growing genetic information companies in the U.S. Invitae Corporation's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. "
target: Clear Genetics
Clear Genetics is a Y Combinator company and leader in developing innovative, patient-centric software to thoughtfully integrate genetics into routine patient care. Their HIPAA-compliant platform offers an automated and comprehensive solution to deliver genetic services at scale.
price ($mm)
$50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/11/2019 via PR Newswire

InVitae, will acquire Jungla Inc.

synopsis: Invitae, a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare, will acquire Jungla, an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests.
buyer: InVitae (NVTA:$389.09)
Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare. They aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Jungla Inc.
Jungla Inc. is an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests. Jungla's technologies combine advances in functional genomics, computational biophysics, cellular engineering, and computer science.
price ($mm)
$50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2017 via PR Newswire

InVitae, acquired CancerGene Connect

synopsis: Invitae Corporation, one of the fastest growing genetic information companies, has acquired Ommdom Inc., which develops healthcare software, including CancerGene Connect, one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories.
buyer: InVitae (NVTA:$389.09)
Invitae is one of the fastest growing genetic information companies in the U.S. Invitae Corporation's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. "
target: CancerGene Connect
CancerGene Connect is one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories. CancerGene Connect was developed by clinicians for clinicians to streamline the collection, analysis, and management of patient family history information.
price ($mm)
$6.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$389.09)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2009 via BusinessWire

Beckman Coulter, Inc., acquired Cogenics

synopsis: Clinical Data, Inc. announced that it has completed the sale of Cogenics, the Company’s genomics services division, to Beckman Coulter, Inc. As previously announced, the sale achieves Clinical Data’s goal to monetize non-core assets and focus resources on advancing its two late-stage targeted therapeutic programs.
buyer: Beckman Coulter, Inc. (BEC:$3,260.60)
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. "
target parent: Clinical Data, Inc.
target: Cogenics
Cogenics’ genomics solutions span current and next generation sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction and biobanking for both research and regulated environments.
price ($mm)
$14
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like YouScript, Inc.


read more

YouScript, Inc.

Elemental Software

Scriptcycle LLC

Curisium

Alfa Kommun & Landsting AB and Safe Care Svenska AB

Verity Solutions

ZappRx

KiViHealth

Zipdrug, Inc.

healthfinch

HealthConnexx LLC

Artemetrx

Rx Infinity Inc.

Creehan & Company

RXTransparent

DoseMe

vMEDEX, Inc.

Prokov Editions

eAudit Solutions

EasyRx LLC

read more

YouScript, Inc.

read more

Ciitizen

YouScript, Inc.

Diploid

Clear Genetics

Jungla Inc.

CancerGene Connect

AltaVoice

read more

Cogenics

Geography
Matching Companies
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$30.36
EBITDA ($mm)
$5.22
EBIT ($mm)
$2.50
Net Income ($mm)
Employees
225
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2020
rev ($mm)
$15.41
EBITDA ($mm)
($7.76)
EBIT ($mm)
($7.93)
Net Income ($mm)
Employees
163
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: NVTA
 
 
 
 
 
 
 
 
InVitae
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today.
year
2021
rev ($mm)
$389.09
EBITDA ($mm)
($510.26)
EBIT ($mm)
($570.07)
Net Income ($mm)
Employees
2600
  • drill down
  • watch
Ticker: BSEM
 
 
 
 
 
 
 
 
BioStem Technologies, Inc.
BioStem Technologies, Inc.
BioStem Technologies, Inc. is engaged in the advancement of regenerative medicine and antiaging strategies throughout the United States, Europe and Mexico. Their goal is to deliver the highest standard wellness and stem cell products that are backed by science.
year
2015
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch